Protalix Biotherapeutics Inc. sell Marianka
Start price
04.04.22
/
50%
€1.76
Target price
04.04.23
€0.000
Performance (%)
-33.28%
End price
18.04.22
€1.17
Summary
This prediction ended on 18.04.22 with a price of €1.17. The SELL prediction by Marianka for Protalix Biotherapeutics Inc. performed very well with a performance of -33.28%. Marianka has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protalix Biotherapeutics Inc. | 0.234% | 0.234% | -62.183% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to Marianka what are the pros and cons of Protalix Biotherapeutics Inc. for the foreseeable future?
Pros
Cons
EBIT decline > 20% expected
Revenue decline > 20% expected
Very low/no dividend yield expected
Sustainability is not important
Mainly gamblers invest here
Junk rating
No uniques
Risky Investment
Decining EBIT margin than peer group
overvalued
very negative Cash Flow expected
Very little Investments for future growth
High risks in the balance sheet
ROE lower than 5% per year
High challenges to pay loans and raise capital
Bad culture
Deficits in Management
No Innovation
Dependend from few customers or products
Growths much slower than the competition
High risks for its business
Nicheplayer
Very high cyclical dependencies
Unknown brand
Outdated or very high risk business model
Comments by Marianka for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
Sell mit Kursziel 0,0